GO:0005590 collagen type VII trimer: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005590 describes the collagen type VII trimer, a homotrimer of three alpha1(VII) chains that forms the structural core of anchoring fibrils.
• The trimer is encoded by COL7A1; its triple-helical domain is flanked by a large N-terminal NC1 domain and a smaller C-terminal NC2 domain.
• Type VII collagen trimers assemble into antiparallel dimers that laterally associate into anchoring fibrils, connecting type IV collagen in the basal lamina to plaques in the underlying connective tissue.
• Mutations in COL7A1 that disrupt trimer folding, secretion, or stability cause dystrophic epidermolysis bullosa, a blistering skin disease.
• Recombinant full-length type VII collagen and truncated minigenes have been developed as research tools and potential therapeutics for dystrophic epidermolysis bullosa.
• Studying this term requires combining structural biology, cell adhesion assays, and CRISPR-based models to dissect trimer assembly and function.
Description
The collagen type VII trimer (GO:0005590) is a cellular component defined as a collagen homotrimer of alpha1(VII) chains. This trimer is the fundamental building block of anchoring fibrils, which are specialized extracellular matrix structures that secure the epidermal basement membrane to the underlying dermis. The trimer's unique architecture, including a long central triple-helical domain flanked by non-collagenous regions, enables it to interact with other matrix components such as laminin and type IV collagen. Understanding this term is critical for researchers studying skin integrity, extracellular matrix assembly, and genetic disorders like dystrophic epidermolysis bullosa. The collagen type VII trimer is not merely a structural element; it is a dynamic player in epidermal-dermal adherence, and its dysfunction leads to severe blistering and scarring. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview of the trimer's composition, assembly, molecular interactions, and relevance to human disease and research methodologies.
collagen type VII trimer At A Glance
| GO ID | GO:0005590 |
|---|---|
| GO term | collagen type VII trimer |
| Ontology | cellular_component |
| Synonym | none |
| Major function | Structural component of anchoring fibrils; binds laminin and connects basal lamina to connective tissue |
| Composition | Homotrimer of three alpha1(VII) collagen chains encoded by COL7A1 |
| Assembly | Triple helix formation followed by antiparallel dimerization and lateral association into anchoring fibrils |
| Key domain | N-terminal NC1 domain mediates interactions with extracellular matrix components |
| Disease relevance | Mutations cause dystrophic epidermolysis bullosa |
What Is GO:0005590?
According to the Gene Ontology, GO:0005590 refers to a collagen homotrimer composed of three alpha1(VII) chains. These trimers are the building blocks of type VII collagen triple helices, which form antiparallel dimers that laterally associate to create anchoring fibrils. Anchoring fibrils connect type IV collagen in the basal lamina to plaques in the underlying connective tissue, and the trimer itself binds laminin. This definition highlights the trimer's dual role: a structural unit that self-assembles into higher-order fibrils and a ligand for other matrix proteins.
Why Is collagen type VII trimer Important in Cell Biology?
The collagen type VII trimer is essential for maintaining the structural integrity of the skin and other stratified epithelia. Its unique ability to form anchoring fibrils that link the basal lamina to the underlying connective tissue provides mechanical stability against shear forces. Dysfunction of this trimer due to COL7A1 mutations leads to dystrophic epidermolysis bullosa, a debilitating blistering disorder with no cure. Moreover, the trimer serves as a model for studying collagen folding, secretion, and extracellular matrix assembly. Research into this term also informs the development of gene and protein therapies, such as recombinant type VII collagen and minigene constructs.
• Provides mechanical anchorage between the epidermis and dermis through anchoring fibrils.
• Mutations in COL7A1 cause dystrophic epidermolysis bullosa, a severe skin blistering disease.
• The trimer's NC1 domain mediates binding to laminin and type IV collagen, critical for basement membrane integrity.
• Recombinant full-length type VII collagen can reverse disease phenotypes in mouse models.
• Truncated minigenes have been developed for gene therapy approaches.
• The hinge region of type VII collagen is intrinsically disordered, affecting flexibility and function.
• Dominant-negative mutations, such as G2043R, highlight the importance of trimer structure.
• Understanding trimer assembly aids in designing treatments for recessive and dominant forms of epidermolysis bullosa.
• The trimer is a target for CRISPR-based gene correction strategies.
• Studying this term bridges extracellular matrix biology and clinical dermatology.
Structure and Composition of collagen type VII trimer
Alpha1(VII) chain and homotrimer formation
In simple terms: Three identical protein chains come together to form a rope-like triple helix.
The collagen type VII trimer is a homotrimer composed of three identical alpha1(VII) chains, each encoded by the COL7A1 gene. Each chain contains a central collagenous triple-helical domain of about 145 kDa, flanked by a large N-terminal non-collagenous NC1 domain and a smaller C-terminal NC2 domain. The chains associate through their collagenous domains to form the triple helix, a process that requires proper folding and post-translational modifications. The NC1 domain is critical for interactions with other matrix proteins and for the antiparallel dimerization of trimers.
NC1 domain and extracellular matrix interactions
In simple terms: The NC1 domain acts like a molecular hook that binds to other proteins in the skin.
The amino-terminal NC1 domain of type VII collagen is a large, globular region that mediates binding to extracellular matrix components, including laminin and type IV collagen. This domain is essential for the anchoring function of the trimer, as it connects the triple helix to the basement membrane and underlying connective tissue. The NC1 domain also plays a role in antiparallel dimer formation, where two trimers align in opposite directions.
Hinge region and flexibility
In simple terms: A flexible hinge in the protein allows it to bend and absorb mechanical stress.
The hinge region of type VII collagen, located within the NC1 domain, is intrinsically disordered, providing flexibility that may be important for its function in skin. This disorder allows the trimer to accommodate mechanical forces and facilitates interactions with other matrix molecules. The hinge region is also a site for mutations that can affect trimer stability and function.
Antiparallel dimerization and anchoring fibril assembly
In simple terms: Trimers pair up in opposite directions and then stack to form strong fibrils.
Type VII collagen trimers assemble into antiparallel dimers, where two triple helices align in opposite orientations, likely through interactions involving the NC1 and NC2 domains. These dimers then associate laterally to form anchoring fibrils, which are long, cross-banded structures that connect the basal lamina to the underlying connective tissue. This higher-order assembly is crucial for the mechanical stability of the skin.
Key Genes Involved in GO:0005590 collagen type VII trimer
The following genes and proteins are central to the biology of the collagen type VII trimer (GO:0005590).
| Gene | Major Role | Research Relevance |
|---|---|---|
| COL7A1 | Encodes the alpha1(VII) chain of type VII collagen | Mutations cause dystrophic epidermolysis bullosa; target for gene therapy |
| LAMA1 | Laminin subunit that binds type VII collagen trimer | Mediates anchoring fibril attachment to basal lamina |
| LAMB1 | Laminin subunit that binds type VII collagen trimer | Component of laminin-332, interacts with NC1 domain |
| LAMC1 | Laminin subunit that binds type VII collagen trimer | Part of laminin-511/521, may interact with type VII collagen |
| COL4A1 | Type IV collagen subunit in basal lamina | Binding partner for anchoring fibrils |
| COL4A2 | Type IV collagen subunit in basal lamina | Binding partner for anchoring fibrils |
| COL4A3 | Type IV collagen subunit in basal lamina | Binding partner for anchoring fibrils |
| COL4A4 | Type IV collagen subunit in basal lamina | Binding partner for anchoring fibrils |
| COL4A5 | Type IV collagen subunit in basal lamina | Binding partner for anchoring fibrils |
| COL4A6 | Type IV collagen subunit in basal lamina | Binding partner for anchoring fibrils |
| FN1 | Fibronectin, extracellular matrix protein | May interact with NC1 domain and influence trimer assembly |
| MMP1 | Matrix metalloproteinase 1 | Degrades type VII collagen; implicated in blistering |
| MMP2 | Matrix metalloproteinase 2 | Degrades type VII collagen; implicated in blistering |
| MMP9 | Matrix metalloproteinase 9 | Degrades type VII collagen; implicated in blistering |
| TIMP1 | Tissue inhibitor of metalloproteinases 1 | Regulates MMP activity against type VII collagen |
| TIMP2 | Tissue inhibitor of metalloproteinases 2 | Regulates MMP activity against type VII collagen |
| HSPG2 | Perlecan, basement membrane proteoglycan | May interact with type VII collagen NC1 domain |
| NID1 | Nidogen-1, basement membrane protein | May interact with type VII collagen NC1 domain |
How Is collagen type VII trimer Regulated?
The expression and assembly of the collagen type VII trimer are regulated at multiple levels. COL7A1 transcription can be influenced by growth factors and cytokines, although specific pathways are not fully detailed in the provided citations. Post-translational modifications, including hydroxylation and glycosylation, are required for proper triple helix formation. The NC1 domain undergoes proteolytic processing, and its interactions with other matrix proteins are critical for anchoring fibril assembly. Matrix metalloproteinases (MMPs) can degrade type VII collagen, and their activity is balanced by tissue inhibitors of metalloproteinases (TIMPs). Mutations that affect folding, secretion, or stability of the trimer lead to disease, underscoring the importance of quality control in the endoplasmic reticulum.
collagen type VII trimer and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| COL7A1 | Recessive dystrophic epidermolysis bullosa | COL7A1 knockout keratinocytes or mouse model |
| COL7A1 | Dominant dystrophic epidermolysis bullosa (e.g., G2043R) | Knock-in mouse expressing mutant COL7A1 |
| COL7A1 | Inversa subtype of recessive DEB | Patient-derived cells or recombinant mutant protein |
| COL7A1 | Gene therapy for DEB | Recombinant minigene or full-length protein administration |
| COL7A1 | Epidermal-dermal adherence defects | In vitro skin equivalents with COL7A1 mutations |
Dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa (DEB) is a genetic blistering skin disorder caused by mutations in COL7A1, leading to defective or absent type VII collagen trimers. Both recessive and dominant forms exist; recessive DEB often results from premature termination codons that reduce trimer levels, while dominant DEB is typically caused by glycine substitutions in the collagenous domain that disrupt triple helix formation. A specific dominant mutation, G2043R, has been reported in a case of DEB. Mutant type VII collagens underlying the inversa subtype of recessive DEB have been characterized, showing defects in secretion and assembly.
Therapeutic approaches
Recombinant full-length type VII collagen expressed in Chinese hamster ovary cells has been shown to reverse the disease phenotype in a mouse model of recessive DEB when administered intravenously. A recombinant truncated type VII collagen minigene has also been developed for gene therapy of DEB. These approaches aim to restore anchoring fibril function by providing functional trimer or its components.
Other collagen-related disorders
While type VII collagen is primarily associated with DEB, mutations in non-collagenous genes can cause osteogenesis imperfecta, highlighting the broader importance of collagen biology. However, this citation is about other collagens and is included to contextualize collagen-related diseases.
From collagen type VII trimer-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of COL7A1 knockout on skin integrity? | COL7A1 knockout keratinocytes or mouse model |
| How does a specific point mutation (e.g., G2043R) affect trimer assembly? | Knock-in mouse or cell line expressing mutant COL7A1 |
| Can wild-type COL7A1 restore anchoring fibrils? | Knock-in of wild-type COL7A1 into patient cells |
| Where does the trimer localize in skin? | Tagged knock-in of COL7A1 with fluorescent protein |
| What happens when COL7A1 is overexpressed? | Overexpression of COL7A1 in keratinocytes or fibroblasts |
| How do mutations affect interactions with laminin? | Point mutations in NC1 domain and binding assays |
How to Study the collagen type VII trimer Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Recombinant expression | Production of full-length or truncated type VII collagen | Studying trimer assembly and function |
| Binding assays | Interactions with laminin, type IV collagen | Mapping NC1 domain binding sites |
| Circular dichroism | Triple helix stability and folding | Assessing mutations affecting collagen structure |
| Immunofluorescence | Localization of type VII collagen in skin | Diagnosing DEB and studying anchoring fibrils |
| Mouse models | Disease phenotype and rescue | Testing recombinant protein or gene therapy |
| Mutational analysis | Effects of specific mutations on trimer | Characterizing dominant and recessive DEB |
| Protein purification | Isolation of type VII collagen trimers | Biochemical and structural studies |
| Gene editing | Correction of COL7A1 mutations | Therapeutic development for DEB |
Recombinant protein expression and purification
Recombinant full-length type VII collagen can be expressed in mammalian cells such as Chinese hamster ovary cells and purified for functional studies. Truncated minigenes have also been developed to study specific domains. These methods allow researchers to characterize trimer assembly, stability, and interactions.
Cell adhesion and binding assays
Binding assays using purified NC1 domain and extracellular matrix components such as laminin and type IV collagen can elucidate the molecular interactions of the trimer. Cell adhesion assays can measure the functional impact of mutations on epidermal-dermal adherence.
Structural analysis
Biophysical techniques such as circular dichroism and nuclear magnetic resonance can assess the triple helix and the intrinsically disordered hinge region. These methods provide insights into the structural basis of trimer function and dysfunction.
Animal models and gene therapy
Mouse models of recessive DEB, such as COL7A1 knockout mice, are used to test therapeutic interventions, including recombinant protein administration and gene therapy. These models are essential for translating findings to clinical applications.
How CRISPR Can Be Used to Study GO:0005590 collagen type VII trimer
Knockout
CRISPR knockout of COL7A1 in keratinocytes or fibroblasts can model recessive DEB by eliminating type VII collagen trimers. These models are useful for studying the consequences of trimer loss on skin integrity and for testing rescue strategies.
Point Mutation
Introducing specific point mutations, such as the glycine substitution G2043R, into COL7A1 via CRISPR can replicate dominant DEB phenotypes. These models help dissect how single amino acid changes disrupt trimer folding and function.
Knock-in
Knock-in of wild-type COL7A1 or tagged versions can restore trimer expression in patient cells or create reporter lines for studying trimer localization and dynamics. This approach is valuable for gene therapy development.
Overexpression
Overexpression of COL7A1 using CRISPR activation or cDNA delivery can increase trimer levels, potentially compensating for mutations. This strategy is being explored for therapeutic benefit in DEB.
How EDITGENE Supports collagen type VII trimer Research
Researchers studying collagen type VII trimer-related genes often need to determine whether a candidate gene is causally involved in trimer assembly, function, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to create precise cellular and animal models, enabling rigorous investigation of GO:0005590 and its associated pathologies.
Contact EDITGENE today to design your custom CRISPR model for collagen type VII trimer research.
Frequently Asked Questions About collagen type VII trimer
What is collagen type VII trimer?
Collagen type VII trimer (GO:0005590) is a homotrimer of three alpha1(VII) collagen chains that forms the core of anchoring fibrils in the skin.
What genes are involved in collagen type VII trimer?
The primary gene is COL7A1, which encodes the alpha1(VII) chain; interacting partners include laminins and type IV collagens.
What diseases are associated with collagen type VII trimer?
Mutations in COL7A1 cause dystrophic epidermolysis bullosa, a severe blistering skin disease.
How is collagen type VII trimer assembled?
Three alpha1(VII) chains form a triple helix, which then dimerizes in antiparallel fashion and associates laterally into anchoring fibrils.
What is the function of the NC1 domain in type VII collagen?
The NC1 domain mediates binding to laminin and type IV collagen, and is essential for anchoring fibril formation.
Can CRISPR be used to study collagen type VII trimer?
Yes, CRISPR knockout, knock-in, and point mutation models are valuable for dissecting trimer function and disease mechanisms.
What are anchoring fibrils?
Anchoring fibrils are structures formed by type VII collagen trimers that connect the basal lamina to the underlying connective tissue.
Is there a treatment for dystrophic epidermolysis bullosa?
Recombinant type VII collagen and gene therapy approaches are under investigation and have shown promise in preclinical models.
What is the role of the hinge region in type VII collagen?
The hinge region is intrinsically disordered, providing flexibility that may be important for mechanical stability.
How can I model collagen type VII trimer dysfunction in the lab?
EDITGENE offers CRISPR knockout, point mutation, knock-in, and overexpression models to study COL7A1 and interacting genes.
Conclusion
The collagen type VII trimer (GO:0005590) is a critical structural component of anchoring fibrils, essential for skin integrity and epidermal-dermal adherence. Its dysfunction leads to dystrophic epidermolysis bullosa, a devastating genetic disorder. Research into trimer assembly, interactions, and regulation has been advanced by recombinant protein technologies and CRISPR-based models. Continued investigation of this term will inform therapeutic strategies, including gene editing and protein replacement, for DEB and related conditions.
References
- 1. Richer BC et al.. 2014. The hinge region of type VII collagen is intrinsically disordered.. Matrix Biol 36:77-83 PMID: 24810542
- 2. Chen M et al.. 2002. The recombinant expression of full-length type VII collagen and characterization of molecular mechanisms underlying dystrophic epidermolysis bullosa.. J Biol Chem 277(3):2118-24 PMID: 11698408
- 3. Chen M et al.. 2000. Development and characterization of a recombinant truncated type VII collagen "minigene". Implication for gene therapy of dystrophic epidermolysis bullosa.. J Biol Chem 275(32):24429-35 PMID: 10821839
- 4. Hou Y et al.. 2015. Intravenously Administered Recombinant Human Type VII Collagen Derived from Chinese Hamster Ovary Cells Reverses the Disease Phenotype in Recessive Dystrophic Epidermolysis Bullosa Mice.. J Invest Dermatol 135(12):3060-3067 PMID: 26203639
- 5. Komatsu K et al.. 2020. A Case of Dominant Dystrophic Epidermolysis Bullosa with a G2043R Mutation in the Type VII Collagen Gene.. Acta Dermatovenerol Croat 28(4):251-252 PMID: 33835003
- 6. Chen M et al.. 1997. Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermal-dermal adherence in human skin.. J Biol Chem 272(23):14516-22 PMID: 9169408
- 7. Marini JC et al.. 2014. Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation.. Curr Opin Pediatr 26(4):500-7 PMID: 25007323
- 8. Woodley DT et al.. 2021. Characterization of mutant type VII collagens underlying the inversa subtype of recessive dystrophic epidermolysis bullosa.. J Dermatol Sci 104(2):104-111 PMID: 34674926
